<DOC>
	<DOCNO>NCT03039686</DOCNO>
	<brief_summary>This multi-center , randomize , double-blind , placebo-controlled study ass efficacy , safety tolerability two different weekly dos BMS-986089 ambulatory boy Duchenne Muscular Dystrophy ( DMD ) .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy , Safety , Tolerability BMS-986089 Ambulatory Boys With Duchenne Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<criteria>Diagnosed DMD blood test Able walk without assistance Able walk 4 stair 8 second less Weigh least 15 kg ( 33 lb ) Taking corticosteroid DMD Any behavior mental issue affect ability complete require study procedure Previously currently take medication like androgen human growth hormone Use ventilator day Unable blood sample collect receive injection skin Other protocol define Inclusion/Exclusion Criteria could apply .</criteria>
	<gender>Male</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>muscular dystrophy</keyword>
	<keyword>Duchenne 's Muscular Dystrophy</keyword>
	<keyword>DMD</keyword>
</DOC>